Boehringer Ingelheim is an independent family-owned company dedicated to researching, manufacturing and marketing innovative products of high therapeutic value for human and veterinary medicine. We are one of the world's 20 leading pharmaceutical companies.
Globally, our business consists of Prescription Medicines, Consumer Health Care, Biopharmaceuticals and Animal Health. We focus on the production of innovative drugs and treatments that represent major therapeutic advances.
Boehringer Ingelheim currently has around 41, 500 employees and 138 affiliates in 47 countries around the globe. Our headquarters is in Ingelheim, a German town where our company was founded in 1885.
In Australia and New Zealand, Boehringer Ingelheim employs around 350 staff who work across our four main business areas: